HighTower Advisors
ABVX

HighTower Advisors’s Abivax ABVX Stock Holding History

HighTower Advisors’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$73.2K – 3726
2024
Q4 		$73.2K Hold
10,000
– – ﹤0.01% 3420
2024
Q3 		$115K Hold
10,000
– – ﹤0.01% 3282
2024
Q2 		$132K Hold
10,000
– – ﹤0.01% 3138
2024
Q1 		$143K Hold
10,000
– – ﹤0.01% 3068
2023
Q4 		$107K Buy
+10,000
New +$102K ﹤0.01% 3182

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

HighTower Advisors's ABVX Position: Q1 2025 in Review

HighTower Advisors sold out of Abivax (ABVX) in Q1 2025, closing a stake of 10,000 shares — an estimated $73.2K sold.

HighTower Advisors first reported a position in ABVX in Q4 2023 and held it in 5 quarters. The position peaked at $143K in Q1 2024. 46 funds tracked by Wall St. Rank hold ABVX as of Q1 2025.

  • HighTower Advisors reported no remaining Abivax position as of Q1 2025 after selling out during the quarter.
  • HighTower Advisors sold 10,000 Abivax shares in Q1 2025, an estimated $73.2K.
  • HighTower Advisors first reported a position in Abivax in Q4 2023 and held it in 5 quarters.
  • HighTower Advisors's Abivax position peaked at $143K in Q1 2024.
  • 46 funds tracked by Wall St. Rank held Abivax as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.